All Pharma News
price-trendAsk Us
ImmuPharma’s Lupus therapy adaptive trial to commence in second half

ImmuPharma’s Lupus therapy adaptive trial to commence in second half
CLINICAL TRIALS ARENA
20 Jun 2023
Share Share
ImmuPharma initiates phase 2/3 clinical trial for lupus treatment

ImmuPharma initiates phase 2/3 clinical trial for lupus treatment
Betsy Goodfellow PHARMAFILE
19 Jun 2023
Share Share
ImmuPharma says it welcomes `helpful` FDA recommendations ahead of ph III study

ImmuPharma says it welcomes `helpful` FDA recommendations ahead of ph III study
PROACTIVEINVESTORS
30 Sep 2022
Share Share
Immupharma PLC: Written Response received from the FDA

Immupharma PLC: Written Response received from the FDA
INVESTIGATE
14 Sep 2022
Share Share
ImmuPharma raises GBP950,000 from broker option

ImmuPharma raises GBP950,000 from broker option
ISE
11 Aug 2022
Share Share
UPDATE on P140 (LUPUZOR™) clinical progress

UPDATE on P140 (LUPUZOR™) clinical progress
PRESS RELEASE
13 Apr 2022
Share Share
FDA approves the Lupzuor PK study

FDA approves the Lupzuor PK study
PRESS RELEASE
12 Aug 2021
Share Share
ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka

ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka
PRESS RELEASE
14 May 2020
Share Share